Helodermatid Venom Exendins: Evolutionary Diversification, Receptor Pharmacology, and Biomedical Translation
International Journal of Molecular Sciences · 20.11.2026 · 27 (22) · 10458
DOI: 10.3390/ijms272210458 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 20.11.2026. Verfasst von Rocio Zatarain-Palacios und 6 weiteren Autor:innen. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Helodermatid exendins provide a framework for examining how venom peptide diversification relates to receptor recognition and biomedical potential. This narrative review integrates published evolutionary models with sequence, structural, and pharmacological evidence for helospectins, helodermin, and exendins-3 and -4. A complementary maximum-likelihood analysis compares 17 precursor-length records and 18 peptide-core records, distinguishing characterized Heloderma sequences from homology-based predictions. Precursor and signal/propeptide analyses support the exendin-3/exendin-4 pair, while the peptide-core analysis supports the helospectin/helodermin pair, revealing region-dependent sequence relationships. We examine how amino acid substitutions, C-terminal variation, and post-translational modifications relate to interactions with class B1 G protein-coupled receptors. Helospectins exhibit species-dependent receptor preferences, while comparisons between exendin-3 and exendin-4 associate limited N-terminal variation with distinct pharmacological profiles in historical pancreatic assays. These observations connect molecular diversity with experimental pharmacology while keeping sequence relationships distinct from receptor selectivity and biological function. Exendin-4-derived therapeutics and imaging agents illustrate the biomedical development of a venom peptide scaffold. Together, the literature synthesis and comparative sequence analysis provide a clearer basis for investigating how exendin variation influences receptor activity and guides the development of venom-derived peptides.
Zitieren
APA
Zatarain-Palacios, R., Rolon-Valencia, T. R., Lino-Lopez, G. J., Dagnino-Acosta, A., Perea-Ruiz, D., Vazquez-Vuelvas, O. F., & Valdez-Velazquez, L. L. (2026). Helodermatid Venom Exendins: Evolutionary Diversification, Receptor Pharmacology, and Biomedical Translation. International Journal of Molecular Sciences, 27(22), 10458. https://doi.org/10.3390/ijms272210458
Vancouver
Zatarain-Palacios R, Rolon-Valencia TR, Lino-Lopez GJ, Dagnino-Acosta A, Perea-Ruiz D, Vazquez-Vuelvas OF, et al. Helodermatid Venom Exendins: Evolutionary Diversification, Receptor Pharmacology, and Biomedical Translation. International Journal of Molecular Sciences. 2026;27(22):10458. doi:10.3390/ijms272210458
BibTeX
@article{ZatarainPalacios2026,
author = {Zatarain-Palacios, Rocio and Rolon-Valencia, Tristan Ramses and Lino-Lopez, Gisela Jareth and Dagnino-Acosta, Adan and Perea-Ruiz, Daniel and Vazquez-Vuelvas, Oscar F. and Valdez-Velazquez, Laura Leticia},
title = {Helodermatid Venom Exendins: Evolutionary Diversification, Receptor Pharmacology, and Biomedical Translation},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {22},
pages = {10458},
doi = {10.3390/ijms272210458}
}
EUVIMED